within Pharmacolibrary.Drugs.ATC.L;

model L01XX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.36666666666666664,
    adminDuration  = 600,
    adminMass      = 0.12,
    adminCount     = 1,
    Vd             = 0.0166,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Amsacrine is an antineoplastic agent used primarily for the treatment of acute lymphoblastic and acute myeloid leukemia. It is a DNA intercalator and a topoisomerase II inhibitor that prevents DNA replication in rapidly dividing cells. Its primary clinical use has diminished with the advent of newer agents, but it is still used in some settings for leukemia therapy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult patients with acute leukemia, treated intravenously with amsacrine as part of chemotherapeutic protocols.</p><h4>References</h4><ol><li><p>Fang, YP, et al., &amp; Tsai, MJ (2016). Amsacrine analog-loaded solid lipid nanoparticle to resolve insolubility for injection delivery: characterization and pharmacokinetics. <i>Drug design, development and therapy</i> 10 1019–1028. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S97161&quot;>10.2147/DDDT.S97161</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27019595/&quot;>https://pubmed.ncbi.nlm.nih.gov/27019595</a></p></li><li><p>Grove, WR, et al., &amp; Wiernik, PH (1982). Review of amsacrine, an investigational antineoplastic agent. <i>Clinical pharmacy</i> 1(4) 320–326. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6764391/&quot;>https://pubmed.ncbi.nlm.nih.gov/6764391</a></p></li><li><p>Jin, Y, et al., &amp; Zhang, W (2018). Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration. <i>Pharmaceutical research</i> 35(1) 13–None. DOI:<a href=&quot;https://doi.org/10.1007/s11095-017-2340-y&quot;>10.1007/s11095-017-2340-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29302821/&quot;>https://pubmed.ncbi.nlm.nih.gov/29302821</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01XX01;
